AAAAAA

   
Results: 1-17 |
Results: 17
Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line
Authors: Wall, NR Beck, FWJ Al-Katib, AM Mohammad, RM
Citation: Nr. Wall et al., Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line, J DRUG TAR, 9(5), 2001, pp. 329-339
Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model
Authors: Mohammad, RM Adsay, NV Philip, PA Pettit, GR Vaitkevicius, VK Sarkar, FH
Citation: Rm. Mohammad et al., Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model, ANTI-CANC D, 12(9), 2001, pp. 735-740
Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy
Authors: Nabha, SM Mohammad, RM Wall, NR Dutcher, JA Salkini, BM Pettit, GR Al-Katib, AM
Citation: Sm. Nabha et al., Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy, ANTI-CANC D, 12(1), 2001, pp. 57-63
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells
Authors: Beck, FWJ Al-Katib, AM Ahmad, I Wall, NR Liu, KZ Mantsch, HH Mohammad, RM
Citation: Fwj. Beck et al., Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells, INT J MOL M, 5(4), 2000, pp. 341-347
Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 inthe human acute lymphoblastic leukemia cell line, Reh
Authors: Wall, NR Mohammad, RM Reddy, KB Al-Katib, AM
Citation: Nr. Wall et al., Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 inthe human acute lymphoblastic leukemia cell line, Reh, INT J MOL M, 5(2), 2000, pp. 165-171
Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: Case report
Authors: Ahmad, I Al-Katib, AM Beck, FWJ Mohammad, RM
Citation: I. Ahmad et al., Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: Case report, CLIN CANC R, 6(4), 2000, pp. 1328-1332
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia
Authors: Varterasian, ML Mohammad, RM Shurafa, MS Hulburd, K Pemberton, PA Rodriguez, DH Spadoni, V Eilender, DS Murgo, A Wall, N Dan, M Al-Katib, AM
Citation: Ml. Varterasian et al., Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia, CLIN CANC R, 6(3), 2000, pp. 825-828
The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model
Authors: Mohammad, RM Wall, NR Dutcher, JA Al-Katib, AM
Citation: Rm. Mohammad et al., The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model, CLIN CANC R, 6(12), 2000, pp. 4950-4956
Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines
Authors: Nabha, SM Wall, NR Mohammad, RM Pettit, GR Al-Katib, AM
Citation: Sm. Nabha et al., Effects of Combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines, ANTI-CANC D, 11(5), 2000, pp. 385-392
Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer
Authors: He, ZQ Evelhoch, JL Mohammad, RM Adsay, NV Pettit, GR Vaitkevicius, VK Sarkar, FH
Citation: Zq. He et al., Magnetic resonance imaging to measure therapeutic response using an orthotopic model of human pancreatic cancer, PANCREAS, 21(1), 2000, pp. 69-76
Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: A model of leukemia in Down syndrome
Authors: Taub, JW Huang, X Ge, YB Dutcher, JA Stout, ML Mohammad, RM Ravindranath, Y Matherly, LH
Citation: Jw. Taub et al., Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: A model of leukemia in Down syndrome, CANCER RES, 60(22), 2000, pp. 6421-6426
A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model
Authors: Mohammad, RM Limvarapuss, C Wall, NR Hamdy, N Beck, FWJ Pettit, GR Al-Katib, A
Citation: Rm. Mohammad et al., A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model, INT J ONCOL, 15(2), 1999, pp. 367-372
Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine
Authors: Mohammad, RM Limvarapuss, C Hamdy, N Dutcher, BS Beck, FWJ Wall, NR Al-Katib, AM
Citation: Rm. Mohammad et al., Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine, INT J ONCOL, 14(5), 1999, pp. 945-950
Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line
Authors: Liu, KZ Schultz, CP Johnston, JB Beck, FWJ Al-Katib, AM Mohammad, RM Mantsch, HH
Citation: Kz. Liu et al., Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line, LEUKEMIA, 13(8), 1999, pp. 1273-1280
Bax : Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh
Authors: Wall, NR Mohammad, RM Al-Katib, AM
Citation: Nr. Wall et al., Bax : Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh, LEUK RES, 23(10), 1999, pp. 881-888
Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh
Authors: Wall, NR Mohammad, RM Nabha, SM Pettit, GR Al-Katib, AM
Citation: Nr. Wall et al., Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh, BIOC BIOP R, 266(1), 1999, pp. 76-80
Induction of apoptosis in breast cancer cells by TPA
Authors: Li, YW Bhuiyan, M Mohammad, RM Sarkar, FH
Citation: Yw. Li et al., Induction of apoptosis in breast cancer cells by TPA, ONCOGENE, 17(22), 1998, pp. 2915-2920
Risultati: 1-17 |